This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Stimulus: Biggest Win, Believe it Or Not, Was Shareholder Value

NEW YORK (TheStreet) -- The final White House report on the effect of the 2009 stimulus came out last week, and was met with a collective yawn. President Obama's Council of Economic Advisers said the $763 billion of tax cuts and spending created or saved 1.6 million jobs a year.

Eeveryone played their assigned role: The New York Times editorial board tut-tutted the remaining doubters, while the libertarian Cato Institute called the analysis "fairy dust''.

But after Washington's windbags have their respective says, we are left with this: Stocks aided by the stimulus have clobbered the market since 2009. In the real world, results like that matter. The business headlines -- not the political ones -- are riddled with success stories that far outweigh the scattered failures of stimulus-backed companies that went bust. As Ronald Reagan once said (on the second try), facts are stubborn things.*

Indeed, back in 2011 I asked tech-consulting shop IDC to put together a list of companies that had been top beneficiaries of the $100 billion IDC estimated that the stimulus would prompt spend on technology -- almost all of it for electronic medical records and new energy technologies. Along with road construction, unemployment insurance and aid to state budgets, this was the biggest chunk of stimulus spending. Then I plugged in their stock prices when President Barack Obama took office in 2009. Here are some highlights of what happened, through Friday's close.

  • A model portfolio of top health-care information technology companies identified by IDC has more than tripled. (In each example here, I assumed I had bought 100 shares of each company, and the results compare to a 99% gain in the Dow Jones Industrial Average). Of these, the top performer was Athenahealth (ATHN), up 476%. (Athenahealth is a political bastard child, co-founded by President George W. Bush's cousin and President Obama's top technology aide).
  • A portfolio of the three now-public companies that took loan money to build factories for next-generation autos has climbed 14-fold. This gain is driven mostly by Tesla (TSLA) -- which built its Model S factory with a government loan deal that included since-redeemed warrants that would have let the government buy Tesla shares for $7.53, or just a smidge below Friday's close of $209.60. The 612% gain for Ford (F), which used stimulus-related financing to refit factories to make fuel-saving EcoBoost engines, and the 159% gain for Nissan (making electric-powered Leafs in a Tennessee plant financed with Energy Department loan guarantees) are just gravy.
  • I count 11 post-2009 initial public offerings of companies that took stimulus money. Most have stumbled after going public -- the list includes at least four biofuels companies and electric car battery maker A123 Systems, which declared bankruptcy. But Tesla's epic performance and SolarCity's (SCTY) climb to $76 from an $8 IPO in 2012 means the list as a whole has jumped almost 120%.  (SolarCity's customers for home-based solar systems could get grants under the stimulus, in lieu of tax breaks).
  • When solar-panel maker Solyndra went broke before it could stage a planned IPO, defaulting on its $535 million stimulus loan to build its factory, Washington made much of a memo from ex-Obama aide Larry Summers saying "government is crappy VC.'' The argument was that the administration couldn't capably do what venture capitalists do to seed the economy. Solyndra wasn't the only failure. Vehicle Production Group (a startup that made natural-gas powered vehicles for the disabled), Fisker Automotive, and A123 all went bankrupt, too.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.99 0.00%
FB $102.01 0.00%
GOOG $682.40 0.00%
TSLA $151.04 0.00%
YHOO $27.04 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs